Evidence map›Paper›PMID 40352720›Full record

ArticleiScience2025

The NONO protein regulates nonclassical DNA structure: Effects on circadian genes and DNA damage.

Ermanno Moriggi, Melissa Pisteljic, Alex Rosi-Andersen, Lennart Opitz, Abdelhalim Azzi, Steven A Brown

Abstract read
In one paragraph

Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ermanno MoriggiInstitute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
Melissa PisteljicInstitute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
Alex Rosi-AndersenInstitute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
Lennart OpitzFunctional Genomic Center Zurich, ETH and University of Zurich, Zurich, Switzerland.
Abdelhalim AzziLaboratory of Lipids and Chronobiology, IMol, Polish Academy of Sciences, Warsaw, Poland.
Steven A BrownInstitute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The DBHS protein family of Nono, PSPC1, and SFPQ regulates diverse aspects of RNA metabolism. Whether these proteins share similar functions is currently unknown. In mouse embryonic fibroblasts (MEFs), we observed around 2000 circadian and non-circadian genes regulated by Nono and PSPC1, with only 35% in common. Considering specifically circadian genes, up- or downregulation by Nono and PSPC1 depends mainly on the gene phase. We postulated a regulatory role of Nono on R-loops, the class of non-B DNA structures that form during transcription. We confirmed this by showing a broad effect of Nono on genome-wide R-loop homeostasis. Interestingly, the R-loop regulation by Nono occurs in a time-of-day dependent manner among the circadian genes. Moreover, we showed a protective role of Nono in a DNA damage cellular model that involves R-loop accumulation. Further studies are required to understand the circadian regulation of R-loops and their implications on gene regulation and disease.

Indexed as

Molecular interactionMolecular mechanism of gene regulationNucleic acidsProperties of biomoleculesTranscriptomics

Identifiers

PMID40352720
PMCPMC12063141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.